BT
BioStem Technologies, Inc.
SEC filingBiotechnology · Pompano Beach, FL
Amount raised$2.5Msold at filing
Total offering$2.5M
Investors in the raise1count reported to the SEC
FiledJun 3, 2026first sale May 21, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Andrew Van VurstExecutive Officer, Director
Brandon PoeExecutive Officer
Kenneth WarringtonDirector
Jodi J. UngrodtDirector
Katherine GorrellExecutive Officer
Thomas J. DuganDirector
Patrick J. DalyDirector
Barry HassettExecutive Officer
Jason MatuszewskiExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.